Yellowstone Biosciences
PrivateLast Round
Series A
Jun 20, 2024
Total Funding Raised
$21M
Company Overview
Yellowstone Biosciences is a biotechnology company that develops soluble bispecific T-cell receptor-based therapies targeting HLA Class II antigens for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Yellowstone Biosciences Comparables
Compare Yellowstone Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stereo Biotherapeutics | 80% | |
| Enara Bio | 78% | |
| T-knife Therapeutics | 78% | |
Yellowstone Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 20, 2024 |
Key People
Founding team and executive leadership
Yellowstone Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Syncona | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 8, 2025
Grew 18% QoQ, from 22 to 26 employees.
- May 4, 2025
Grew 19% QoQ, from 21 to 25 employees.
Yellowstone Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Yellowstone Biosciences's valuation, stock price, and market status.